Search Results - "Joshi, Anagha M."

Aberrant signaling of immune cells in Sjögren’s syndrome patient subgroups upon interferon stimulation by Sarkar, Irene, Davies, Richard, Aarebrot, Anders K., Solberg, Silje M., Petrovic, Aleksandra, Joshi, Anagha M., Bergum, Brith, Brun, Johan G., Hammenfors, Daniel, Jonsson, Roland, Appel, Silke

“…Background Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease, characterized by mononuclear cell infiltrates in the salivary and lacrimal…”
Get full text

A NEW REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR THE SIMULTANEOUS ESTIMATION OF SERRATIOPEPTIDASE AND DICLOFENAC SODIUM IN BULK AND TABLET DOSAGE FORM by Kulkarni B, Manasi, Joshi M, Anagha

“…Objective: The objective is to study the development of a simple, rapid, specific, precise, and accurate reversed-phase high-performance liquid chromatography…”
Get full text

AN EXPERIMENTAL DESIGN APPROACH FOR OPTIMIZATION OF MODIFIED COLORIMETRIC FIRST-ORDER DERIVATIVE METHOD FOR ESTIMATION OF SERRALYSIN IN BULK AND PHARMACEUTICAL FORMULATION by B, Kulkarni Manasi, Anagha M, Joshi

“…Objective: The aim of the present work is to use experimental design to screen and optimize experimental variables for developing a colorimetric first-order…”
Get full text

A NEW REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR THE SIMULTANEOUS ESTIMATION OF SERRATIOPEPTIDASE AND DICLOFENAC SODIUM IN BULK AND TABLET DOSAGE FORM by Kulkarni B, Manasi, Joshi M, Anagha

“…Objective: The objective is to study the development of a simple, rapid, specific, precise, and accurate reversed-phase high-performance liquid chromatography…”
Get full text

A NOVEL HPTLC METHOD FOR SIMULTANEOUS DETERMINATION OF CO-ENZYME Q10 AND α-TOCOPHEROL IN BULK AND PHARMACEUTICAL FORMULATION by Kulkarni, Manasi B., Joshi, Anagha M., Patil, Rohini V.

“…Objective: HPTLC Method for Simultaneous quantification of co-enzyme Q10 and α-tocopherol in bulk and capsule dosage form was developed and validated as per…”
Get full text

EXAGGERATION OF TYPE 2 DIABETES DUE TO CAFFEINE-NICOTINE CO-ADMINISTRATION: A STUDY IN RATS by Kumbhar, Subhash T., Une, Hemant D., Joshi, Anagha M., Wangikar, Pralhad B.

“…Objective: This study evaluated the toxic effect of simultaneously injected normal doses of caffeine and nicotine in diabetic lab animals.Methods: A study was…”
Get full text